Not applicableUnknownNCT05735704What this trial is testingEarly Detection and Screening of Hematological Malignancies - SANGUINEWho this might be right forHematologic Malignancy JaxBio Ltd 3,000
Early research (Phase 1)Ended earlyNCT00354185What this trial is testingPXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00002504What this trial is testingInterleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Not applicableLooking for participantsNCT06823960What this trial is testingStudy to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)Who this might be right forMarginal Zone Lymphoma(MZL) IRCCS Azienda Ospedaliero-Universitaria di Bologna 59
Testing effectiveness (Phase 2)Study completedNCT04433156What this trial is testingVR-CAP in the First-line Treatment for Patients With Marginal Zone LymphomaWho this might be right forMarginal Zone Lymphoma Henan Cancer Hospital 26
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Early research (Phase 1)Study completedNCT00769288What this trial is testingFAU in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more National Cancer Institute (NCI) 12
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT02049541What this trial is testingStudy of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more Kami Maddocks, MD 18
Not applicableStudy completedNCT00896662What this trial is testingAnalysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202Who this might be right forLymphomaSolid Tumor Vanderbilt-Ingram Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00058305What this trial is testingBryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell TransplantationWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT03028103What this trial is testingOpen-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor PatientsWho this might be right forDiffuse Large B Cell LymphomaPrimary Mediastinal LymphomaMantle Cell Lymphoma+2 more Epizyme, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00031642What this trial is testingMonoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell TransplantationWho this might be right forLymphoma University of Nebraska 26
Not applicableStudy completedNCT00453206What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Wake Forest University Health Sciences 66
Large-scale testing (Phase 3)Study completedNCT01996865What this trial is testingLenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.Who this might be right forLymphoma, Non-Hodgkin Celgene 503
Early research (Phase 1)Study completedNCT04578600What this trial is testingCC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell LymphomaWho this might be right forIndolent B-Cell Non-Hodgkin LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic Leukemia+16 more Joseph Tuscano 8
Testing effectiveness (Phase 2)Ended earlyNCT00012298What this trial is testingRadiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more National Cancer Institute (NCI) 81